Emergence of babesiosis in China-Myanmar border areas
© Zhou et al. 2015
Received: 1 May 2015
Accepted: 1 July 2015
Published: 25 July 2015
E. Vannier and P. J. Krause presented an excellent article on “Babesiosis in China, an emerging threat” in the Lancet Infectious Diseases in December 2014, which updated research on human babesiosis in China. However, a neglected and emerging issue has not been mentioned in EV & PJK’s article, that is the co-infections with B. microti and P. falciparum parasites that exist in syndemic areas, spatially in the China-Myanmar border areas of Yunnan province, China. Therefore, two important issues are addressed in here, including (i) the new emerging infections with Babesia spp. which are normally ignored in malaria endemic areas due to similarities in pathogenic morphology and clinical symptoms, (ii) additional consideration on babesiosis rather than drug-resistant malaria when anti-malaria treatment for the febrile cases in clinics fails.
To the Editor
To promote correct identification and effective control of babesiosis and malaria in syndemic areas, clinical doctors and public health workers should be aware of the following information: (i) how to apply the molecular technologies to clearly distinguish babesiosis from malaria in order to overcome the difficulties in microscopy diagnosis due to their similarities in morphology and clinical symptoms, and (ii) to consider human babesiosis rather than drug-resistant malaria when febrile cases in anti-malaria treatment fail.
This work was supported by the National Natural Science Foundation of China (no. 81273192).
- Vannier E, Krause PJ. Babesiosis in China, an emerging threat. Lancet Infect Dis. 2014;20:896–7.Google Scholar
- Vannier E, Krause PJ. Human babesiosis. N Engl J Med. 2012;366(25):2397–407.PubMedView ArticleGoogle Scholar
- Zhou X, Xia S, Huang JL, Tambo E, Ge HX, Zhou XN. Human babesiosis, an emerging tick-borne disease in the People’s Republic of China. Parasites & Vectors. 2014;7(1):509.Google Scholar
- Zhou X, Li SG, Wang JZ, Huang JL, Zhou HJ, Chen JH, et al. Emergence of human babesiosis along the border of China with Myanmar: detection by PCR and confirmation by sequencing. Emerg Microb Infect. 2014;2014(3):e55.Google Scholar
- Sun Y, Li SG, Jiang JF, Wang X, Zhang Y, Wang H, et al. Babesia venatorum infection in Child, China. Emerg Infect Dis. 2014;20(5):896–7.Google Scholar
- Jiang JF, Zheng YC, Jiang RR, Li H, Huo QB, Jiang BG, et al. Epidemiological, clinical, and laboratory characteristics of 48 cases of “Babesia venatorum” infection in China: a descriptive study. Lancet Infect Dis. 2014;15(2):196–203.PubMedView ArticleGoogle Scholar
- Zhou X, Li SG, Chen SB, Wang JZ, Xu B, Zhou HJ, et al. Co-infections with Babesia microti and Plasmodium parasites along the China-Myanmar border. Infect Dis Poverty. 2013;2(1):24.PubMed CentralPubMedView ArticleGoogle Scholar
- Krause PJ. Babesiosis diagnosis and treatment. Vector Borne Zoonotic Dis. 2003;3(1):45–51.PubMedView ArticleGoogle Scholar
- Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379(9830):1960–6.PubMed CentralPubMedView ArticleGoogle Scholar
- Goo YK, Terkawi MA, Jia H, Aboge GO, Ooka H, Nelson B, et al. Artesunate, a potential drug for treatment of Babesia infection. Parasitol Int. 2010;59(3):481–6.Google Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.